Feasibility study to assess the impact of the exercise app RheumaFit on quality of life, pain, physical function and health competency of patients with rheumatic diseases

Feasibility study to assess the impact of the exercise app RheumaFit on quality of life, pain, physical function and health competency of patients with rheumatic diseases - RheumaFit

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00037095

Enrollment

Registered

2025-06-03

Start date

2025-07-16

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06.9

Interventions

Group 1: Patients who use the Rheuma-Fit app daily for 3 months if possible. The recommendation for daily use is 5-15 minutes.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with rheumatoid arthritis or psoriatic arthritis who fulfill the ACR/EULAR classification criteria, written informed consent, required age: between 18-70 years.

Exclusion criteria

Exclusion criteria: No signed declaration of consent, age < 18 years, change of medication in the last 3 months, pregnancy.

Design outcomes

Primary

Measure	Time frame
1. Does physical activity (IPAQ, WHO-Activity, HAQ) increase from baseline to follow-up (12weeks) when using the fitness app RheumaFit (through measurements and questionnaires)? 2. Can the quality of life (SF-36)of patients with rheumatic joint disease be improved from baseline to follow-up (12weeks) using the fitness app RheumaFit (through questionnaire)? 3. How does fatigue (FACIT) change in rheumatic patients from baseline to follow-up (12weeks) using the RheumaFit app (through questionnaire)? 4. Can pain (PAIN, VRS) be reduced in patients with rheumatic diseases from baseline to follow-up (12weeks) using the fitness app RheumaFit (through questionnaire)?	—

Measure

Time frame

1. Does physical activity (IPAQ, WHO-Activity, HAQ) increase from baseline to follow-up (12weeks) when using the fitness app RheumaFit (through measurements and questionnaires)? 2. Can the quality of life (SF-36)of patients with rheumatic joint disease be improved from baseline to follow-up (12weeks) using the fitness app RheumaFit (through questionnaire)? 3. How does fatigue (FACIT) change in rheumatic patients from baseline to follow-up (12weeks) using the RheumaFit app (through questionnaire)? 4. Can pain (PAIN, VRS) be reduced in patients with rheumatic diseases from baseline to follow-up (12weeks) using the fitness app RheumaFit (through questionnaire)?

—

Secondary

Measure	Time frame
1. Is there an improvement in health and physical activity (HLS-EU-Q16, PAHCO) competency when using the fitness app RheumaFit for rheumatic diseases from baseline to follow-up (12weeks)? (through questionnaires) 2. How does the fitness app RheumaFit influence the fear of movement (TSK) in patients with rheumatic diseases from baseline to follow-up (12weeks)? (through questionnaires)	—

Countries

Germany

Contacts

Public ContactHarriet Morf

Uniklinik Erlangen

harriet.morf@uk-erlangen.de+4991318543023

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026